World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
35430
World Ranking
9623
National Ranking
936

Overview

Robert Huddart is affiliated with the Institute of Cancer Research in the United Kingdom. Their research primarily spans the field of Medicine, with specific focus across several subfields including Surgery, Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, and Molecular Biology.

The key topics of their work encompass Bladder and Urothelial Cancer Treatments, Testicular Diseases and Treatments, Urinary and Genital Oncology Studies, Sarcoma Diagnosis and Treatment, Advanced Radiotherapy Techniques, Cancer Immunotherapy and Biomarkers, and Neuroblastoma Research and Treatments.

Frequent collaborators in Robert Huddart's research include:

  • S. Hafeez
  • Emma Hall
  • H. McNair
  • Yohann Loriot
  • Ananya Choudhury

Their publications often appear in the following venues:

  • Journal of Clinical Oncology
  • Annals of Oncology
  • Radiotherapy and Oncology
  • Clinical Oncology
  • Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature

Some of their recent papers include:

  • Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up, 2021, Annals of Oncology
  • Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma, 2023, New England Journal of Medicine
  • Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium, 2021, Journal of Clinical Oncology
  • Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up, 2022, Annals of Oncology
  • Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium, 2021, Journal of Clinical Oncology

Best Publications

  • Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma

    Y. Loriot;A. Necchi;S. H. Park;J. Garcia-Donas

  • Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial

    David P Dearnaley;Matthew R Sydes;John D Graham;Edwin G Aird

  • Multiple newly identified loci associated with prostate cancer susceptibility.

    Rosalind A Eeles;Rosalind A Eeles;Zsofia Kote-Jarai;Graham G Giles;Graham G Giles;Ali Amin Al Olama

  • Radiotherapy with or without Chemotherapy in muscle-invasive bladder cancer

    Nicholas D. James;Syed A. Hussain;Peter Jenkins;Jean Tremlett

  • European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I

    Susanne Krege;Jörg Beyer;Rainer Souchon;Peter Albers

  • Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array

    Rosalind A. Eeles;Ali Amin Al Olama;Sara Benlloch;Edward J. Saunders

  • European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG)

    H. J. Schmoll;R. Souchon;S. Krege;P. Albers

  • Cardiovascular Disease as a Long-Term Complication of Treatment for Testicular Cancer

    R.A. Huddart;A. Norman;M. Shahidi;A. Horwich

  • The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20.

    T.J. Postma;N.K. Aaronson;J.J. Heimans;M.J. Muller

  • Stereotactic body radiotherapy for oligometastases.

    Alison C Tree;Vincent S Khoo;Rosalind A Eeles;Merina Ahmed

  • Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System).

    Valeria Panebianco;Yoshifumi Narumi;Ersan Altun;Bernard H. Bochner

  • Identification of seven new prostate cancer susceptibility loci through a genome-wide association study

    Rosalind A. Eeles;Zsofia Kote-Jarai;Ali Amin Al Olama;Graham G. Giles;Graham G. Giles

  • Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial

    David P Dearnaley;David P Dearnaley;Gordana Jovic;Isabel Syndikus;Vincent Khoo

  • Testicular germ-cell cancer

    Alan Horwich;Janet Shipley;Robert Huddart

  • Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial.

    Thomas Powles;Thomas Powles;Tibor Csőszi;Mustafa Özgüroğlu;Nobuaki Matsubara

  • Antibacterial Prophylaxis after Chemotherapy for Solid Tumors and Lymphomas

    Michael Cullen;Neil Steven;Lucinda Billingham;Claire Gaunt

  • Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours

    J. M. O’Sullivan;R. A. Huddart;A. R. Norman;J. Nicholls

  • Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study.

    Roy Vergis;Catherine M Corbishley;Andrew R Norman;Jaclyn Bartlett

  • Variants near DMRT1 , TERT and ATF7IP are associated with testicular germ cell cancer

    Clare Turnbull;Elizabeth A Rapley;Sheila Seal;David Pernet

  • A genome-wide association study of testicular germ cell tumor.

    Elizabeth A Rapley;Clare Turnbull;Ali Amin Al Olama;Emmanouil T Dermitzakis

Frequent Co-Authors

Alan Horwich
Alan Horwich Royal Marsden NHS Foundation Trust
David P. Dearnaley
David P. Dearnaley Institute of Cancer Research
Chris Parker
Chris Parker Institute of Cancer Research
Vincent Khoo
Vincent Khoo Royal Marsden NHS Foundation Trust
A. R. Norman
A. R. Norman Royal Marsden NHS Foundation Trust
Rosalind A. Eeles
Rosalind A. Eeles Institute of Cancer Research
Nicholas D. James
Nicholas D. James Institute of Cancer Research
Douglas F. Easton
Douglas F. Easton University of Cambridge
Janet Shipley
Janet Shipley Institute of Cancer Research
Sophie D. Fosså
Sophie D. Fosså Oslo University Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine opens up a wide range of online degree options that complement or provide alternative paths to traditional medical school. For those interested in specialized nursing, exploring pmhnp online programs is a flexible way to become a Psychiatric Mental Health Nurse Practitioner, a growing field within mental health.

If you're drawn to the broader healthcare system, a health care administration online degree can prepare you to lead hospitals, clinics, or other medical facilities. These programs are a great fit for those interested in the business and organizational aspects of healthcare.

For graduate-level advancement, check out the cheapest mha programs online to find cost-effective ways to deepen your knowledge in healthcare administration.

Finally, nurses aiming for the highest credentials might be interested in the least expensive dnp programs, which offer doctoral-level training affordably and conveniently online.

Best Scientists Citing Robert Huddart

Trending Scientists